CMS(867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity
Written by Customer Service on . Posted in Public Companies.
Boskalis 2025 annual results: strong financial performance with EBITDA of EUR 1.3 billion and net profit of EUR 775 million
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Preliminary Statement of Results for the year ended 31 December 2025
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Admiral Group Plc Full Year 2025 Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
MBWS Becomes the Exclusive Distributor of Flor de Caña Rum in France
Written by Customer Service on . Posted in Public Companies.
Cabka delivers disciplined SHIFT execution in 2025 with EBITDA growth and significant net debt reduction
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Fiscal year 2025: RENK Group AG achieves annual targets with new record revenue and order backlog
Written by Customer Service on . Posted in Public Companies.
BioVersys to Report Its Full Year 2025 Financial Results, Provide a Business Update and Host a Conference Call
Written by Customer Service on . Posted in Public Companies.
WISeKey Reports FY 2025 Preliminary Financial Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
